Resources on psoriatic disease and COVID-19

Name: IFPA
Price range: $

22 June 2021

By IFPA

IFPA has collected useful resources to navigate the uncertainties of these times.

Last updated June 22, 2021

Advocacy

"Together we will overcome"	Advocacy Toolkit for psoriasis and psoriatic arthritis during COVID-19
Global Psoriasis Coalition	Statement on COVID-19

Registries

PsoProtect	https://psoprotect.org/
PsoProtectMe	https://psoprotectme.org/

Dermatology

American Association of Dermatology	Academy Coronavirus Resource Center Academy guidance on the use of biologics
British Association of Dermatology	Advice for dermatology health care providers Advice Regarding self-isolation and immunosuppressed patients
European Dermatology Guidelines	Coronavirus Statement
National Psoriasis Foundation	Guidance Statements

Scientific journals

Journal of the European Academy of Dermatology and Venereology	JEADV COVID-19 articles
Journal of the American Academy of Dermatology	Collection of articles on COVID-19 Biologics for psoriasis during COVID-19 outbreak - reply

International organizations

World Health Organization	Coronavirus disease (COVID-19) pandemic
Centers for Disease Control and Prevention (CDC)	Coronavirus (COVID-19) Pandemic
European CDC	COVID-19 Information
NCD Alliance	Calls to action for non-communicable diseases Resources relevant to non-communicable diseases
International Psoriasis Council	Statement on COVID-19

National resources

ARGENTINA	Coronavirus y pacientes con Psoriasis
AUSTRALIA	Coronavirus (Covid-19)
AUSTRIA	STELLUNGNAHME ZUM CORONA VIRUS
BANGLADESH	করোনায় করণীয়
BELGIUM - FLANDERS	Corona en biologics
BELGIUM - WALLONIA	Covid-19 et dermatoses inflammatoires
BRAZIL	CORONAVÍRUS – Informações e recomendações
CANADA	English French
CROATIA	misljenje o lijecenju tijekom razdoblja epidemije covid-19
CZECH REPUBLIC	Aktuálně o koronaviru
DENMARK	Udrulning af vacciner
FINLAND	Koronavirus ja psoriasis/
FRANCE	Informations sur le covid-19 pour les adultes et les enfants/
GERMANY	Herausforderungen in Zeiten von Corona Coronavirus: Änderungen im Versorgungsalltag
GREECE	COVID19
IRELAND	Information on Covid-19 and Skin Conditions
ISRAEL	קורונה-ופסוריאזיס
ITALY	Articoli correlati a Psoriasi e Coronavirus
JAPAN	COVID-19（新型コロナウイルス感染症）について
THE NETHERLANDS	CORONAVIRUS: "Geen reden tot paniek"
NORWAY	Aktuelt NHI Coronavirus og COVID-19 Skin Friendly Handwashing
PORTUGAL	O DOENTE PSORIÁTICO NO CONTEXTO COVID-19
SLOVENIA	COVID 19 novice
SPAIN	COVID-19: Centro de Información
SWEDEN	Experterna om coronaviruset och psoriasis/psoriasisartrit Försiktighetsåtgärder med anledning av coronaviruset Har du frågor om coronaviruset (covid-19)?
SWITZERLAND	Statement Coronavirus: Aktuell
TAIWAN	防疫期間的自我健康管理
UNITED KINGDOM	COVID-19 Hints and Tips
UNITED STATES	Resource Center Guidance Statements Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
VIETNAM	Youtube

More resources on psoriatic disease and COVID-19

report Advocacy

”Together we will overcome”: advocacy toolkit for psoriatic disease during COVID-19

article Advocacy

IFPA Coalition's statement on COVID-19

article

PsoProtect

statistics Statistics

New findings from PsoProtectMe

statistics Latest Research, Living with Psoriatic Disease ...

Disease flare study from PsoProtectMe

statistics Latest Research, Statistics ...

First findings published: psoriasis and COVID-19 study from PsoProtect

news Latest Research, Statistics ...

Psoriatic disease, COVID-19 and mental health

article Advocacy

A time for prudence, science, and facts

Information available from external sources does not constitute IFPA’s official advice. The information on this page is not intended as a substitute for professional medical advice, diagnosis, or treatment. Please note that IFPA can not guarantee the accuracy, relevance, timeliness, or completeness of any information from external sources. Always refer to the World Health Organization and local healthcare authorities for the most up-to-date information about COVID-19.